Security key
74587V107
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)
CUSIP: 74587V107
Q1 2015 13F Holders as of 31 Mar 2015
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,633,071
- Total 13F shares
- 29,120,599
- Share change
- +1,968,920
- Total reported value
- $6,873,292,525
- Put/Call ratio
- 90%
- Price per share
- $236.11
- Number of holders
- 194
- Value change
- +$477,852,182
- Number of buys
- 112
- Number of sells
- 75
Report period
Q1 2015
Institutions
194
Top holders
10
PBYI full security history
Newer quarter: Q2 2015
Previous quarter: Q4 2014
PUMA BIOTECHNOLOGY, INC. SEC filings
PUMA BIOTECHNOLOGY, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74587V107
Recent filing periods:
Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
11%
|
5,686,668
|
$1,076,316,000 | — | 31 Dec 2014 | |
| FMR LLC |
13F
|
Company |
8.1%
|
4,035,436
|
$763,787,000 | — | 31 Dec 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.6%
|
2,766,701
|
$523,653,000 | — | 31 Dec 2014 | |
| Capital Research Global Investors |
13F
|
Company |
3.9%
|
1,944,740
|
$368,081,000 | — | 31 Dec 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
1,523,115
|
$288,280,000 | — | 31 Dec 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.2%
|
603,082
|
$114,145,000 | — | 31 Dec 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.1%
|
555,391
|
$105,119,000 | — | 31 Dec 2014 | |
| BB BIOTECH AG |
13F
|
Company |
1.1%
|
521,991
|
$98,797,000 | — | 31 Dec 2014 | |
| Capital International Investors |
13F
|
Company |
1%
|
503,700
|
$95,335,000 | — | 31 Dec 2014 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
497,090
|
$94,090,000 | — | 31 Dec 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.96%
|
474,185
|
$89,749,000 | — | 31 Dec 2014 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.93%
|
463,566
|
$87,739,000 | — | 31 Dec 2014 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.83%
|
413,856
|
$78,330,525 | — | 31 Dec 2014 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
0.77%
|
384,598
|
$72,793,000 | — | 31 Dec 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.7%
|
346,552
|
$65,592,000 | — | 31 Dec 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
251,710
|
$47,641,000 | — | 31 Dec 2014 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.51%
|
250,900
|
$47,488,000 | — | 31 Dec 2014 | |
| ORBIS HOLDINGS LTD |
13F
|
Company |
0.46%
|
230,633
|
$43,652,000 | — | 31 Dec 2014 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.45%
|
224,869
|
$42,560,000 | — | 31 Dec 2014 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.44%
|
220,000
|
$41,639,000 | — | 31 Dec 2014 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.42%
|
209,825
|
$39,714,000 | — | 31 Dec 2014 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
206,698
|
$39,122,000 | — | 31 Dec 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.41%
|
203,455
|
$38,508,000 | — | 31 Dec 2014 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.4%
|
200,163
|
$37,885,000 | — | 31 Dec 2014 | |
| CAPITAL GUARDIAN TRUST CO |
13F
|
Company |
0.38%
|
191,000
|
$36,151,000 | — | 31 Dec 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.38%
|
190,160
|
$35,991,000 | — | 31 Dec 2014 | |
| NORGES BANK |
13F
|
Company |
0.35%
|
174,901
|
$33,103,000 | — | 31 Dec 2014 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.32%
|
161,300
|
$30,529,000 | — | 31 Dec 2014 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.32%
|
159,400
|
$30,170,000 | — | 31 Dec 2014 | |
| WEATHERBIE CAPITAL, LLC |
13F
|
Company |
0.25%
|
124,826
|
$23,626,000 | — | 31 Dec 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
123,395
|
$23,354,000 | — | 31 Dec 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
123,217
|
$23,321,000 | — | 31 Dec 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
106,441
|
$20,144,000 | — | 31 Dec 2014 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.21%
|
104,263
|
$19,734,000 | — | 31 Dec 2014 | |
| Redmile Group, LLC |
13F
|
Company |
0.19%
|
93,865
|
$17,766,000 | — | 31 Dec 2014 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.17%
|
84,150
|
$15,927,000 | — | 31 Dec 2014 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.17%
|
82,200
|
$15,558,000 | — | 31 Dec 2014 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.16%
|
78,741
|
$14,903,000 | — | 31 Dec 2014 | |
| LMR Partners LLP |
13F
|
Company |
0.15%
|
76,819
|
$14,539,000 | — | 31 Dec 2014 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.15%
|
74,794
|
$14,156,000 | — | 31 Dec 2014 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.14%
|
71,075
|
$13,453,000 | — | 31 Dec 2014 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.14%
|
67,932
|
$12,857,000 | — | 31 Dec 2014 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
66,014
|
$12,495,000 | — | 31 Dec 2014 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.13%
|
63,064
|
$11,936,000 | — | 31 Dec 2014 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.13%
|
62,100
|
$11,754,000 | — | 31 Dec 2014 | |
| Invesco Ltd. |
13F
|
Company |
0.12%
|
60,778
|
$11,503,000 | — | 31 Dec 2014 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.12%
|
59,644
|
$11,289,000 | — | 31 Dec 2014 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.12%
|
58,800
|
$11,129,000 | — | 31 Dec 2014 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.12%
|
57,889
|
$10,957,000 | — | 31 Dec 2014 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.11%
|
56,962
|
$10,781,000 | — | 31 Dec 2014 |
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q1 2015
As of 31 Mar 2015,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,120,599 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Institutional Trust Company, N.A., and JANUS CAPITAL MANAGEMENT LLC.
This page lists
194
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
183
Q1 2015 holders
194
Holder diff
11
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 Value $ | Q1 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.